Nikolas Eleftheriadis1,2*, Haruo Ikeda2, Manabu Onimaru2, Ioanna Bravita1, Eleni Eleftheriadou1, Grace Santi2 and Haruhiro Inoue2
1Kyanous Stauros Euromedica, Thessaloniki, Greece
2Digestive Diseases Center, Showa University, Koto Toyosu Hospital, Japan
*Corresponding Author: Nikolas Eleftheriadis, Gastroenterologist, Kyanous Stauros Euromedica, Greece.
Received: November 25, 2019; Published: January 23, 2020
Keywords: GERD; Antireflux Mucosectomy; Barrett΄S Esophagus; Nissen Fundoplication
Gastroesophageal reflux disease (GERD) is defined as symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus. Medical, endoscopic, and open/laparoscopic surgical methods are used to treat GERD.
Over the last years a number of anti-reflux endoluminal procedures (suturing, injections, implants and radiofrequency energy application) have been developed for treating GΕRD, thus obviating the need for long-term proton pump inhibitors (PPI) and the potential morbidity of laparoscopic fundoplication. Although all these techniques were able to improve symptoms, the quality of life, PPI use and esophageal acid reduction were unremarkable. Moreover, some early endoscopic procedures have failed or proven unsafe, while no single endoscopic modality has been yet proved or accepted as the endoscopic therapy of choice for GERD.
Citation: Nikolas Eleftheriadis.,et al. “Antireflux Mucosectomy (ARMS): Innovative Endoscopic Treatment for Resistant Gastroesophageal Reflux (GERD)”. Acta Scientific Gastrointestinal Disorders 3.2 (2020): 20-21.
Copyright: © 2020 Nikolas Eleftheriadis.,et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.